chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was given 1st dose of pediatric covid vaccine 1 day after the expiration date of 2/28/2022, vaccine was administered 3/1/2022
Came to ER with nausea, cough, SOB, and generalized weakness.
Unknown if this is correlated or not. Pt with hx scleroderma. On 6/23/21 EF was >55%, RVSP 39 mmHg. On 1/11/22 presented with CP and elevated HS troponin (>9,000). Echo 1/11/22 showed severe hypokinesis of posterolateral wall with EF 40-45%. RVSP 37 mmHg. Cath 1/12/22 showed normal coronary anatomy. Patient had her first Moderna injection 1/28/22 and felt ill the next day. Symptoms progressed and she presented to hospital 1/30/22  with CHF sx. HS troponin 5,400. BNP 2200. Echo 1/31/22 showed EF 25% (global dysfunction), mod-sev MR, and RVSP >60 mmHg. Started milrinone. Hypotension has prohibited aggressive afterload reduction and BB. Now on dobutamine. The timing of the rapid deterioration of LV systolic function in relation to C-19 immunization is concerning. Labs 2/3/22: CRP 13.0 (nml <10); ESR 45. Patient still hospitalized.
This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain) and MYALGIA (muscle pain in middle of back near spine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced BACK PAIN (back pain) and MYALGIA (muscle pain in middle of back near spine). At the time of the report, BACK PAIN (back pain) and MYALGIA (muscle pain in middle of back near spine) outcome was unknown.            No concomitant and treatment medications were reported.
48hr p/vax pt exp sudden onset of vertigo, nausea, & fever;sx intermittent over next 4-5 days w/inc dizziness, fatigue & numbness & tingling to hands & legs, vertigo cont intermittently as well;vertigo remains but diminished;
Information has been received from a health professional concerning a 7 year old male patient who on 11/6/99 was vaccinated with a dose of varicella virus vaccine live. Subsequently, on approximately 4/9/04, the patient developed breakthrough chicken pox with less than 50 lesions. Follow up information indicated that there was not a single report of adverse reaction following varicella vaccination. The reporter indicated that 49 other patients developed breakthrough cases of chicken pox. No additional information is expected.
11/2 Patient came in for Pre-Surgical PASS appointment. COVID test result from 11/2/21 is noted to be POSITIVE. Pt asymptomatic.
Starting 5 hours after injection: mild body aches and headache. Starting 29 hours after injection and continuing till 53 hours after injection: Body shakes and temperature over 103 degrees, reduced to 102 degrees with actetominaphen. Aches, mild nausea and diarrhea. Fatigue and loss of appetite. Day 4 after injection: Temperature maintained 100-102 degrees, aches, little appetite, fatigue. Day 5 after injection: Temperature normal, mild headache, some energy and appetite at time of preparing this report.
EXTREMELY BLURRY VISION. I could not see my face standing in front of mirror. I had to put my nose on the mirror to see my face. Went to 3 different mirrors and was the same. The morning of 8/13/2021 my signt was a little better in the morning and fine by end of that day. I also had body aches
Onset of severe pain base of skull, neck & across shoulders, w/resulting weakness; also exp myalgia, flaccid paralysis; unable to pick up objects; muscle dec, hyeresthesia, reflexes difficult to illicit; poss GBS; SEE WORM VERY DETAILED;
Fever, body and muscle aches, weakness, fatigue, loss of appetite, lethargic, headache She did not have this with Pfizer 1 and 2 doses
I noticed ringing in my ears in 2021 during times when I was studying for school in a quiet room. I scheduled an appointment with my PCP and was referred to an ENT office. They ordered an MRI with and without contrast to rule out any visible causes of the ringing. MRI was normal.  Also did an audiogram but hearing was normal. I have reduced caffeine intake and now manage high cholesterol, but ringing persists.   The ringing in my ears is constant, and sometimes manifests as a pulsatile tinnitus.
PATIENT HAD A MILD HEADACHE AND TEMP FOR 12 HOURS AFTER THE VACCINE. HE TREATED THE SYMPTOMS WITH IBUPROFEN AND NYQUIL AT NIGHT AND SAID THAT IT HELPED. THE SYMPTOMS RESOLVED WITHIN 12 HOURS.
Pt came for last HPV vaccine but stated that he had 2 reactions after the vaccines. Bilateral arm and hand rash/itching for 3-4 days where he went to ER for eval and it resolved on own.
knot in arm near injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (knot in arm near injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE NODULE (knot in arm near injection site). At the time of the report, VACCINATION SITE NODULE (knot in arm near injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  It was reported that patient did not have an adverse reaction. She just had a bump.    Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Clinical course of information updated.
very sick; couldn't move for several days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   Previously administered products included Covid 19 vaccine (received on an unknown date).   On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced sickness (Verbatim: very sick) and mobility decreased (Verbatim: couldn't move for several days).  The outcome of the sickness and mobility decreased were resolved.   It was unknown if the reporter considered the sickness and mobility decreased to be related to RSV vaccine.     It was unknown if the company considered the sickness and mobility decreased to be related to RSV vaccine.   Additional Information: GSK receipt date: 24-SEP-2023 The case was received from the patient interactive digital media. The patient got his/her shot and was very sick and could not move for several days. The patient stated that would never get it again, his/her COVID shots were a breeze. The follow-up could not be possible as no contact details were available.
Tired; I woke up this morning, my back was killing me, I could hardly move; I do have arthritis and I do get slight arthritis in the morning but this was really bad; This is a spontaneous report from a contactable consumer (patient). An 87-year-old patient of unspecified gender received bnt162b2 (BNT162B2, lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. Medical history included ongoing arthritis. Concomitant medications were not reported. The patient stated, "I had the vaccine on Friday, I had a shot and it was fine. I got a little tired after it, but I was alright the next 2 days till Sunday. I woke up this morning (24Jan2021), my back was killing me, I could hardly move. And I am 87 years old and I do have arthritis (further clarification unknown) and I do get slight arthritis in the morning, but this was really bad. And I have been walking around and trying to exercise and it seems to be getting better. But I was wondering why I got it so severe if it was from the vaccine or what?" Outcome of the event arthritis was recovering, while outcome of other events was unknown.   Information about batch/lot number has been requested.
The day of the shot in the evening I developed a rash on my upper arm. It itched. I visited the doctor the following day for the rash. That night the rash grew  to my forearm on the inside which lasted 48 hours. Second shot no side effects.
I had the first shot in January. I didn't really notice any thing yet. I had the second shot in Feb and started noticing shoulder pain. Since I already had neck issues, I didn't connect the vaccine to the shoulder. The pain got to where I could not lift my shoulder I then got the booster in Nov 2021. Almost immediately the other shoulder (each injection site?) was in pain and I could not lift the shoulder Seeing doctors for two years, getting treatment. Slowly shoulder has been getting better, but not all the way yer=t.
After booster I started feeling nauseous and it feels like vertigo. It?s lasted every day since the last shot December 2021.
Sx, bodyache, nasal congestion, cough since 7/29. Forced scheduled for test 7/30. Vaccinated. Roommate is Pos. The last day worked was on 7/28.
warm palm; Bumps on both hands; Right foot bumps; Bumps on wrist; Arm soreness; Runny nose; Taste metallic; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), RHINORRHOEA (Runny nose), DYSGEUSIA (Taste metallic), URTICARIA (Bumps on wrist) and FEELING HOT (warm palm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Drug allergy (Allergic to morphine.). Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol, METFORMIN for Diabetes mellitus, LISINOPRIL for Hypertension, NORTRIPTYLINE for Nerve pain, BRIVARACETAM (BRIVIACT), PHENOBARBITAL and TOPIRAMATE (TROKENDI XR) for Seizure, FUROSEMIDE (LASIX [FUROSEMIDE]) for Water retention, VITAMIN D NOS and ASCORBIC ACID (VITAMINS C) for an unknown indication.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), RHINORRHOEA (Runny nose) and DYSGEUSIA (Taste metallic). On 15-Apr-2021, the patient experienced URTICARIA (Bumps on wrist). On 17-Apr-2021, the patient experienced FEELING HOT (warm palm), URTICARIA (Bumps on both hands) and URTICARIA (Right foot bumps). At the time of the report, PAIN IN EXTREMITY (Arm soreness), RHINORRHOEA (Runny nose), DYSGEUSIA (Taste metallic), URTICARIA (Bumps on wrist), FEELING HOT (warm palm), URTICARIA (Bumps on both hands) and URTICARIA (Right foot bumps) outcome was unknown.
Became hot and felt itching minutes after receiving vaccine. No swelling of lip or tongue or throat. No rash. No shortness of breath. ER doctor on site evaluated and determined this was not likely to be an allergic reaction.
Patient has experienced joint pain, body aches  3 weeks after receiving  Pfizer  Bivalent vaccine. Patient took advil which helped with the
heart palpitation; dizziness; body aches; 101 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitation), DIZZINESS (dizziness), PAIN (body aches) and PYREXIA (101 degrees Fahrenheit) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 041B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced PALPITATIONS (heart palpitation), DIZZINESS (dizziness), PAIN (body aches) and PYREXIA (101 degrees Fahrenheit). At the time of the report, PALPITATIONS (heart palpitation), DIZZINESS (dizziness), PAIN (body aches) and PYREXIA (101 degrees Fahrenheit) outcome was unknown.            No concomitant medications were mentioned. Treatment medication reported includes Tylenol.  Denied to follow-up with Safety team   Reporter did not allow further contact
Pt was administered the Pfizer bivalent 5-11 dose instead of the Pfizer bivalent 6mo-4yo dose.
Pt. woke up 1/23/21 with a red, swollen area at injection sight. By Tuesday 1/25, pt. says arm was red, very warm and swollen. She came to office on 1/28/21 and arm had an approx. 3 in by 3 in area that was red and warm to touch, not swelling noted. Pt. will try Benadryl and cold compresses on arm. I
round red warm area @ site of vax 3 1/2cm wide & 4cm long;another round red itchy area mid chest 2 1/2cm long & 3 1/2cm wide;
doses administered after more than 1 temperature excursion; doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021 at 10:01 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient age was reported as 72.66. No concomitant medication was provided. It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.   The BUD date was reported as 13-Mar-2021, and the date of vaccine moved to fridge was reported as 11-Feb-2021. No treatment medication was provided
Noted to be sleepier than normal from PM of 01/12/04, after receiving vaccines through entire day of 01/13/04 although he awoke every 4 hours to feed.  Had temperature ranging from 100.2-100.4 on 01/13/04.  At 20:30 on 01/13/04 (28 hours after receiving vaccines) mom heard noise in crib, on arrival baby had stooled and vomited.  When she picked him up he was pale and limp and although his eyes were open he seemed unresponsive as if he were staring.  Shortly after he had rapid blinking of one eye only.  No tonic extension or tonic/clonic and no cyanosis or respiratory difficulty.
Stiff neck (R) side, shoulder on (R) side stiff, nausea, dizziness, cough, hard to breath, extremely painful to sit, lie down flat. Treatment 7 days of Prednisone 10mg, 7 days Cyclobenzaprine 10mg three times day, Hydrocod/APAP 7.5/500 q 4-6 hrs for pain.
Patient experienced nausea and vomiting the day after the vaccine. Did not have any other recent changes that would have caused it.
Nausea vomiting and diarrhea developed to the point of requiring hospitalization 3-4-21 to 3-5-21.
Feeling hot; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Feeling hot), NAUSEA (Nausea) and VOMITING (Vomiting) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced FEELING HOT (Feeling hot), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, FEELING HOT (Feeling hot), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.
Her body is deteriorating; hard at hearing; She doesn't know what is happening; Tongue doesn't look right.; I have all of the symptoms after the vaccine; She has been experiencing pain; Her gums are sore; Her tongue is turning red; Her throat is sore now; inappropriate dose scheduling; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Her throat is sore now), PAIN (She has been experiencing pain), GINGIVAL PAIN (Her gums are sore), TONGUE ERYTHEMA (Her tongue is turning red) and GENERAL PHYSICAL HEALTH DETERIORATION (Her body is deteriorating) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate dose scheduling). On 26-Jun-2021, the patient experienced OROPHARYNGEAL PAIN (Her throat is sore now). On 05-Jul-2021, the patient experienced PAIN (She has been experiencing pain), GINGIVAL PAIN (Her gums are sore) and TONGUE ERYTHEMA (Her tongue is turning red). On 26-Jul-2021, the patient experienced PARAESTHESIA ORAL (Tongue doesn't look right.) and DISCOMFORT (I have all of the symptoms after the vaccine). On an unknown date, the patient experienced GENERAL PHYSICAL HEALTH DETERIORATION (Her body is deteriorating), HYPOACUSIS (hard at hearing) and CONFUSIONAL STATE (She doesn't know what is happening). On 15-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate dose scheduling) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Her throat is sore now), PAIN (She has been experiencing pain), GINGIVAL PAIN (Her gums are sore), TONGUE ERYTHEMA (Her tongue is turning red), GENERAL PHYSICAL HEALTH DETERIORATION (Her body is deteriorating), HYPOACUSIS (hard at hearing), CONFUSIONAL STATE (She doesn't know what is happening), PARAESTHESIA ORAL (Tongue doesn't look right.) and DISCOMFORT (I have all of the symptoms after the vaccine) outcome was unknown.            Concomitant product use was not provided by the reporter.    Treatment information was not provided.  On an unknown date, it was reported that the patient was administered the COVID-19 molecular test. The results were negative.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow-up recieved- Event updated , dose details updated
Dizziness, vertigo, nausea, weakness, hypotension, generalized body aches, dehydration, severe effects lasted 6 days, lesser effects 2 additional days. Right arm (injection arm but not site specific) entire arm extremely painful. No redness or swelling noted. Noted extreme amount by volume of urination for 2 days. The first 12 hours voided large amount every 1-2 hours.
COVID arm, itchy raised rash about 3"x2", warm to the touch, lasted about a week.
body aches; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches) and PYREXIA (Low grade fever) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches) and PYREXIA (Low grade fever). At the time of the report, MYALGIA (body aches) and PYREXIA (Low grade fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication details were not reported by the reporter.  Partent took Antihistamines daily as treatment medications.   This case was linked to MOD-2021-435530, MOD-2021-435537 (Patient Link).
chest pain; starting bleeding from his mouth; rashes all over his body; body aches all over his body; lost appetite; Underweight; started losing strength all over his body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 13 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jun2021 10:00 (Batch/Lot number: unknown) at the age of 13 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Premature baby" (unspecified if ongoing). There were no concomitant medications. The following information was reported: CHEST PAIN (non-serious) with onset 02Jul2021, outcome "not recovered", described as "chest pain"; MOUTH HAEMORRHAGE (non-serious) with onset 02Jul2021, outcome "not recovered", described as "starting bleeding from his mouth"; RASH (non-serious) with onset 02Jul2021, outcome "not recovered", described as "rashes all over his body"; PAIN (non-serious) with onset 02Jul2021, outcome "not recovered", described as "body aches all over his body"; DECREASED APPETITE (non-serious) with onset 02Jul2021, outcome "not recovered", described as "lost appetite"; UNDERWEIGHT (non-serious) with onset 02Jul2021, outcome "not recovered", described as "Underweight"; ASTHENIA (non-serious) with onset 02Jul2021, outcome "not recovered", described as "started losing strength all over his body". The events "chest pain", "starting bleeding from his mouth", "rashes all over his body", "body aches all over his body", "lost appetite", "underweight" and "started losing strength all over his body" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were not taken as a result of chest pain, mouth haemorrhage, rash, pain, decreased appetite, underweight, asthenia.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (18Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.  Additional information: After receiving the Pfizer vaccine in 30Jun2021 after two days the patient started getting rashes all over his body, he then started losing strength all over his body, lost appetite, started bleeding from his mouth, body aches all over his body and chest pain. At first his reactions were stable but after a month they started getting worse day by day. Patient have no strength and very underweight. Patient did not had any other vaccine in four weeks. Patient did not have other medications in two weeks. If Patient did not have COVID prior vaccination. Patient was not tested for COVID post vaccination. Patient did not have Known allergies.